#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia chromosome positive Chronic cutaneous lupus erythematosus Follicle centre lymphoma follicular grade I, II – III Progressive multifocal leukoencephalopathy Craniocerebral injury Non-small cell lung cancer recurrent Blastic plasmacytoid dendritic cell neoplasia Diabetes insipidus Hidradenitis Hepatitis D Gastrointestinal stromal tumour Anal cancer recurrent Primary adrenal insufficiency Mucopolysaccharidosis I Thrombotic microangiopathy More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome Haemophilia B without inhibitors – Diagnostics Mantle cell lymphoma Waldenstrom’s macroglobulinaemia recurrent – Treatment Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Idiopathic inflammatory myopathy – Basic Information Antisynthetase syndrome – Basic Information Mast cell activation syndrome – Treatment Haemophilia A with anti factor VIII Hereditary optic atrophy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eik1003 Corifollitropin Alfa Psma-11 Dasatinib Sodium Hyaluronate Gebasaxturev Meldonium Edg-5506 Letetresgene Autoleucel Calcium Folinate Eftrenonacog Alfa Gsk4011499 Calcium Oxybate Lamivudine Azetukalner L-Ascorbic Acid AZD3632 Trastuzumab Deruxtecan Palbociclib Dorocubicel More therapies…

    Learn about Your Condition

    Acarodermatitis Cystic fibrosis Neurotrophic keratopathy Lennox-Gastaut syndrome Meningococcal infection Testicular germ cell cancer Transferrin decreased Diminished ovarian reserve Retinopathy of prematurity Primary hyperaldosteronism Cluster headache Peripheral artery restenosis Coma Pulmonary congestion Prader-Willi syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colitis ulcerative

  • Study on the Effectiveness of Ozanimod for Children with Moderate to Severe Ulcerative Colitis Not Responding to Usual Treatment

    Recruiting

    4 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Ozanimod
    Belgium France Germany Poland Spain

  • Study of controlled-release nicotinamide (CICR-NAM) tablets for treating mild to moderate ulcerative colitis

    Recruiting

    4 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Nicotinamide
    Germany

  • Study Comparing Ustekinumab, Infliximab, and Combination Therapy for Patients with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Infliximab
    • Ustekinumab
    Poland

  • Study Comparing Vedolizumab and Infliximab for Children Aged 6-17 with Ulcerative Colitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    • Infliximab
    Poland

  • Study on the Effectiveness of Infliximab, Tofacitinib, and Vedolizumab in Patients with Ulcerative Colitis Resistant to Initial Treatment

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • Vedolizumab
    • Infliximab
    • Tofacitinib
    Poland

  • Study Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Adalimumab
    France
Previous Page
1 … 4 5 6 7 8 … 20
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!